Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
(Celecoxib + ciprofloxacin) by NeuroSense Therapeutics for Alzheimer's Disease: Likelihood of Approval
(Celecoxib + ciprofloxacin) is under clinical development by NeuroSense Therapeutics and currently in Phase II for Alzheimer's Disease. According to...